A survey of hepatitis C management by Victorian GPs after PBS-listing of direct-acting antiviral therapy.

Abstract

Most respondents were interested in prescribing DAAs, but education, access to transient elastography and clear consultation pathways are required to translate this interest into increased treatment availability. PBS eligibility of current injectors needs promotion.